The PCPT trial

The PCPT trial is the first phase III trial with the principal objective of examining the hypothesis that the use of chemoprevention could prevent the development of prostate cancer. This is a large scale randomised clinical trial comparing finasteride (5-α reductase inhibitor) to placebo. A total o...

詳細記述

書誌詳細
主要な著者: Hamdy, F, Rouprêt, M
フォーマット: Journal article
言語:French
出版事項: 2008